These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22018488)

  • 1. Cardiac resynchronization therapy to prevent life-threatening arrhythmias in patients with congestive heart failure.
    Kurita T; Noda T; Aiba T; Nakajima I; Shimizu W; Motoki K; Yasuoka R; Miyazaki S; Kamakura S
    J Electrocardiol; 2011; 44(6):736-41. PubMed ID: 22018488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure.
    Gold MR; Linde C; Abraham WT; Gardiwal A; Daubert JC
    Heart Rhythm; 2011 May; 8(5):679-84. PubMed ID: 21185401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac resynchronization therapy: a review of proarrhythmic and antiarrhythmic mechanisms.
    Turitto G; El-Sherif N
    Pacing Clin Electrophysiol; 2007 Jan; 30(1):115-22. PubMed ID: 17241325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.
    Thijssen J; Borleffs CJ; Delgado V; van Rees JB; Mooyaart EA; van Bommel RJ; van Erven L; Boersma E; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2011 Nov; 58(22):2282-9. PubMed ID: 22093504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
    Boriani G; Gasparini M; Landolina M; Lunati M; Proclemer A; Lonardi G; Iacopino S; Rahue W; Biffi M; DiStefano P; Grammatico A; Santini M;
    Eur J Heart Fail; 2011 Aug; 13(8):868-76. PubMed ID: 21558331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential proarrhythmic effect of cardiac resynchronization therapy during perioperative period: data from a single cardiac center.
    Luo NS; Yuan WL; Lin YQ; Chen YX; Mao XQ; Xie SL; Kong MY; Zhou SX; Wang JF
    Chin Med J (Engl); 2010 Sep; 123(17):2295-8. PubMed ID: 21034537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Goldenberg I; Hall WJ; Beck CA; Moss AJ; Barsheshet A; McNitt S; Polonsky S; Brown MW; Zareba W
    J Am Coll Cardiol; 2011 Aug; 58(7):729-37. PubMed ID: 21816309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
    Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
    Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of cardiac resynchronization therapy for patients with refractory congestive heart failure].
    Mu HY; Lin T; Ma YO; Tang BP; Shi XK; Liu ZQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Oct; 37(10):878-82. PubMed ID: 20137535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular evidence of reverse cardiac remodeling induced by cardiac resynchronization therapy.
    Orrego CM; Nasir N; Oliveira GH; Flores-Arredondo JH; Cordero-Reyes AM; Loebe M; Youker KA; Torre-Amione G
    Congest Heart Fail; 2011; 17(3):140-6. PubMed ID: 21609388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
    Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ
    Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac resynchronization therapy with defibrillation capability: considerations on a not yet proven therapeutic superiority].
    Berisso MZ; Canonero D; Caruso D; Setti S; Domenicucci S
    G Ital Cardiol (Rome); 2010 Apr; 11(4):295-305. PubMed ID: 20677575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recoordination rather than resynchronization predicts reverse remodeling after cardiac resynchronization therapy.
    Wang CL; Wu CT; Yeh YH; Wu LS; Chang CJ; Ho WJ; Hsu LA; Luqman N; Kuo CT
    J Am Soc Echocardiogr; 2010 Jun; 23(6):611-20. PubMed ID: 20418055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence and causes of nonresponse to cardiac resynchronization therapy in patients with congestive heart failure].
    Wang DM; Han YL; Zang HY; Yu HB; Zhou WW; Zhang DH; Tian Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Oct; 38(10):895-900. PubMed ID: 21176632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome.
    van Bommel RJ; Borleffs CJ; Ypenburg C; Marsan NA; Delgado V; Bertini M; van der Wall EE; Schalij MJ; Bax JJ
    Eur Heart J; 2010 Nov; 31(22):2783-90. PubMed ID: 20693544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
    Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C
    Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.